About
R&D
Approach
Therapeutic areas
Scientific publications
R&D centers
Scientific and medical board
Scientific partnerships
Pipeline
Overview
TOTUM•63
Lipidrive® (TOTUM•070)
TOTUM•854
TOTUM•448
Manufacturing
Investors
Presentation
Shareholder space
Financial Information
Breakdown of Share Capital
Financial Calendar
Regulatory information
Annual General Meeting
Newsroom
News
Releases
Media resources
FR
EN
E-Shop
Valbiotis’ regulatory information
Accueil
»
Regulatory Information
Select a date :
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
Select a category :
All
Annual & half-year financial report
Company statutes
Investors presentation
Liquidity contract
Number of shares and voting rights monthly report
Universal Registration Document
All regulatory information